Early steroid withdrawal after liver transplantation for hepatocellular carcinoma.

AIM To evaluate the impact of early steroid withdrawal on the incidence of rejection, tumor recurrence and complications after liver transplantation for advanced-stage hepatocellular carcinoma. METHODS Fifty-four patients underwent liver transplantation for advanced-stage hepatocellular carcinoma from April 2003 to June 2005. These cases were divided into a steroid-withdrawal group (group A, n = 28) and a steroid-maintenance group (group B, n = 26). In group A, steroid was withdrawn 3 mo after transplantation. In group B, steroid was continuously used postoperatively. The incidence of rejection, 6-mo and 1-year recurrence rate of carcinoma, 1-year survival rate, mean serum tacrolimus trough level, and liver and kidney function were compared between the two groups. RESULTS In the two groups, no statistical difference was observed in the incidence of rejection (14.3 vs 11.5%, P > 0.05), mean serum tacrolimus trough levels (6.9 +/- 1.4 vs 7.1 +/- 1.1 microg/L, P > 0.05), liver and kidney function after 6 mo [alanine aminotransferase (ALT): 533 +/- 183 vs 617 +/- 217 nka/L, P > 0.05; creatinine: 66 +/- 18 vs 71 +/- 19 micromol/L, P > 0.05], 6-mo recurrence rate of carcinoma (25.0 vs 42.3%, P > 0.05), and 1-year survival rate (64.2 vs 46.1%, P > 0.05). The 1-year tumor recurrence rate (39.2 vs 69.2%, P < 0.05), serum cholesterol level (3.9 +/- 1.8 vs 5.9 +/- 2.6 mmol/L, P < 0.01) and fasting blood sugar (5.1 +/- 2.1 vs 8.9 +/- 3.6 mmol/L, P < 0.01) were significantly different. These were lower in the steroid-withdrawal group than in the steroid-maintenance group. CONCLUSION Early steroid withdrawal was safe after liver transplantation in patients with advanced-stage hepatocellular carcinoma. When steroids were withdrawn 3 mo post-operation, the incidence of rejection did not increase, and there was no demand to maintain tacrolimus at a high level. In contrast, the tumor recurrence rate and the potential of adverse effects decreased significantly. This may have led to an increase in long-term survival rate.

[1]  D. Samuel,et al.  Steroid withdrawal at day 14 after liver transplantation: A double‐blind, placebo‐controlled study , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  Z. Chen,et al.  The survival and value of liver transplantation for liver carcinoma: a single-center experience. , 2004, Transplantation proceedings.

[3]  J. Hepp,et al.  Rapid steroid taper and neoral monotherapy in liver transplantation in Chile: a step in the right direction? , 2004, Transplantation proceedings.

[4]  T. Roskams,et al.  Steroid‐free immunosuppression during and after liver transplantation – a 3‐yr follow‐up report , 2003, Clinical transplantation.

[5]  Jung‐Ta Chen,et al.  Roles of the glucocorticoid receptor in resectable hepatocellular carcinoma. , 2002, Surgery.

[6]  O. Ciccarelli,et al.  Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression – 5 year results of a prospective study , 2001, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  J. Fung,et al.  REASONS FOR LONG-TERM USE OF STEROID IN PRIMARY ADULT LIVER TRANSPLANTATION UNDER TACROLIMUS12 , 2001, Transplantation.

[8]  H. Yazawa,et al.  Glucocorticoid hormone suppression of human neutrophil‐mediated tumor cell cytostasis , 1999, International journal of cancer.

[9]  M. Stegall,et al.  Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. , 1997, Transplantation.

[10]  M. Stegall,et al.  Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss , 1997, Hepatology.

[11]  R. Busuttil,et al.  A randomized prospective trial of steroid withdrawal after liver transplantation. , 1995, Transplantation.

[12]  R. Merion,et al.  Corticosteroid withdrawal after liver transplantation. , 1995, Surgery.

[13]  V. Mazzaferro,et al.  Milan multicenter experience in liver transplantation for hepatocellular carcinoma. , 1994, Transplantation proceedings.

[14]  J. Neuberger,et al.  Steroid withdrawal from long-term immunosuppression in liver allograft recipients. , 1993, Transplantation.

[15]  T. Starzl,et al.  Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation , 1991, Cancer.